Cerebrolysin recalls
The FDA has published 2 recalls involving Cerebrolysin since 2020. The latest was reported on 15 Oct 2025. Most were for sterility. GenoGenix has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2020
Last 12 months1reported
Class I00% of total
Ongoing2latest 15 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why cerebrolysin is recalled
Companies
By year
Ongoing cerebrolysin recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cerebrolysin for Injection, all strengths and presentations recalled | GenoGenix | Sterility | Nationwide |
| Drug | CLASS II | Cerebrolysin, 107.5 MG/ML vial recalled by Advanced Nutriceuticals | Advanced Nutriceuticals | Sterility | 7 states |
All cerebrolysin recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Cerebrolysin for Injection, all strengths and presentations recalled | GenoGenix | Sterility | Nationwide |
| Drug | CLASS II | Cerebrolysin, 107.5 MG/ML vial recalled by Advanced Nutriceuticals | Advanced Nutriceuticals | Sterility | 7 states |
Should you stop taking Cerebrolysin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.